Core Insights - Thermo Fisher Scientific Inc reported better-than-expected earnings for Q3, with earnings of $5.79 per share, surpassing the analyst consensus estimate of $5.49 per share [1] - The company achieved quarterly sales of $11.122 billion, exceeding the analyst consensus estimate of $10.908 billion [1] Company Performance - Marc N. Casper, the CEO, highlighted the operational performance and the effectiveness of the company's growth strategy, including new product launches and collaborations with OpenAI [2] - Following the earnings announcement, Thermo Fisher Scientific shares increased by 0.1%, closing at $567.20 [2] Analyst Ratings and Price Targets - Citigroup analyst Patrick Donnelly maintained a Neutral rating on Thermo Fisher Scientific and raised the price target from $500 to $580 [5] - Barclays analyst Luke Sergott maintained an Overweight rating and increased the price target from $585 to $625 [5]
Thermo Fisher Scientific Analysts Increase Their Forecasts After Upbeat Q3 Earnings